Floatz logo

Flurbiprofen Axetil

Flubiprofen Axetil

Peking University First HospitalPhase 4 / ApprovedDormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Flubiprofen Axetil cohort.

Asset / SponsorPhaseRating
SUFENTANYL
Peking University First Hospital
Phase 4BB
DEXAMETHASONE
Peking University First Hospital
Phase 4BB

Same molecule, other indications

Flurbiprofen Axetil is also rated in:

Enhanced Recovery After SurgeryDormant
B
Indicative ·
56 / 100
View asset →
Multimodal AnalgesiaDormant
B
Indicative ·
56 / 100
View asset →
DexamethasoneDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →